Application of MBL in preparing drug for preventing or treating obesity and method for screening drug for preventing or treating obesity

A drug, technology for obesity, applied in the field of biotechnology and medicine
CN110051824AActive Publication Date: 2019-07-26XINXIANG MEDICAL UNIV
3 Cites 1 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Patent Type
Applications(China)
Current Assignee / Owner
XINXIANG MEDICAL UNIV
Publication Date
2019-07-26

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to application of MBL in preparing a drug for preventing or treating obesity and a method for screening the drug for preventing or treating the obesity, and belongs to the technical field of biotechnology and medicine. The MBL levels of normal control serum and obese patient serum are studied, and the MBL level of the obese patient serum is obviously less than the normal control serum. The gene editing technology is utilized to obtain mannose-binding lectin gene-deficient mice and find that MBL gene knockout significantly aggravates the blood glucose metabolism disorder in obese mice, and the fat cell volume is increased. An experiment of MBL inhibiting adipocyte differentiation shows that MBL can inhibit the adipocyte differentiation by down regulating the adipogenicdifferentiation related genes C / EBP alpha and PPAR gamma. From above, the MBL and the obesity have a close relationship. Therefore, the mannose-binding lectin can be used for preparing the drug for preventing or treating the obesity and preparing the drug for inhibiting the adipogenic differentiation of 3T3-L1 preadipocytes.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the application of MBL in preparing the medicine for preventing or treating obesity and the method for screening the medicine for preventing or treating obesity, belonging to the fields of biotechnology and medical technology. Background technique

[0002] A series of metabolic disorders caused by obesity, such as type 2 diabetes, non-alcoholic fatty liver, cardiovascular and cerebrovascular diseases, etc., currently lack effective methods to curb and treat obesity. Adipose tissue is generated through the differentiation of adipose-derived mesenchymal stem cells (MSCs). The increase in the number and volume of fat cells will cause the increase of adipose tissue, which will lead to obesity. The increased number of adipocytes is caused by excessive proliferation and differentiation of preadipocytes, while the increased volume of adipocytes is caused by increased accumulation of intracellular triglycerides. Because obesity is ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More